KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?

References

• Fanger CM, Ghanshani S, Logsdon NJ et al. Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J. Biol. Chem.274, 5746–5754 (1999).
   PubMed Web of Science ®Google Scholar
• Wulff H, Kolski-Andreaco A, Sankaranarayanan A et al. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr. Med. Chem.14, 1437–1457 (2007).
   PubMed Web of Science ®Google Scholar
• Ishii TM, Silvia C, Hirschberg B et al. A human intermediate conductance calcium-activated potassium channel. Proc. Natl Acad. Sci. USA94, 11651–11656 (1997).
   PubMed Web of Science ®Google Scholar
• Logsdon NJ, Kang J, Togo JA et al. A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J. Biol. Chem.272, 32723–32736 (1997).
   PubMed Web of Science ®Google Scholar
• Wang ZH, Shen B, Yao HL et al. Blockage of intermediate-conductance-Ca2+-activated K+ channels inhibits progression of human endometrial cancer. Oncogene26, 5107–5114 (2007).
   PubMed Web of Science ®Google Scholar
• Begenisich T, Nakamoto T, Ovitt CE et al. Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J. Biol. Chem.279, 47681–47687 (2004).
   PubMed Web of Science ®Google Scholar
• Burgess MA, Bodey GP. Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob. Agents Chemother.2, 423–426 (1972).
   Google Scholar
• Wojtulewski JA, Gow PJ, Walter J et al. Clotrimazole in rheumatoid arthritis. Ann. Rheum. Dis.39, 469–472 (1980).
   PubMedGoogle Scholar
• Alvarez J, Montero M, Garcia-Sancho J. High affinity inhibition of Ca2+-dependent K+ channels by cytochrome P-450 inhibitors. J. Biol. Chem.267, 11789–11793 (1992).
   PubMed Web of Science ®Google Scholar
• Benzaquen LR, Brugnara C, Byers HR et al. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat. Med.1, 534–540 (1995).
   PubMed Web of Science ®Google Scholar
• Wulff H, Miller MJ, Hansel W et al. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc. Natl Acad. Sci. USA97, 8151–8156 (2000).
   PubMed Web of Science ®Google Scholar
• Stocker JW, De Franceschi L, McNaughton-Smith GA et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood101, 2412–2418 (2003).
   PubMed Web of Science ®Google Scholar
• Spear K. Novel tritylamides as potent, selective blockers of the Gardos potassium ion channel. Presented at: Strategic Research Institute Conference on Ion Channels in Drug Discovery and Development. Philadelphia, PA, USA, 20–21 May (2002).
   Google Scholar
• Romanenko VG, Nakamoto T, Srivastava A et al. Regulation of membrane potential and fluid secretion by Ca2+-activated K+ channels in mouse submandibular glands. J. Physiol.581(Pt 2), 801–817 (2007).
   PubMedGoogle Scholar
• Nakamoto T, Srivastava A, Romanenko VG et al. Functional and molecular characterization of the fluid secretion mechanism in human parotid acinar cells. Am. J. Physiol. Regul. Integr. Comp. Physiol.292, R2380–R2390 (2007).
   Google Scholar
• Flores CA, Melvin JE, Figueroa CD et al. Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice after inactivation of the intermediate conductance Ca2+-dependent K+ channel Kcnn4. J. Physiol.583(Pt 2), 705–717 (2007).
   Google Scholar
• Si H, Heyken WT, Wolfle SE et al. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ. Res.99, 537–544 (2006).
   PubMed Web of Science ®Google Scholar
• Ataga KI, Orringer EP, Styles L et al. Dose-escalation study of ICA-17043 in patients with sickle cell disease. Pharmacotherapy26, 1557–1564 (2006).
   Google Scholar
• Crane GJ, Gallagher N, Dora KA et al. Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. J. Physiol.553(Pt 1), 183–189 (2003).
   Google Scholar
• Gillham JC, Myers JE, Baker PN et al. Regulation of endothelial-dependent relaxation in human systemic arteries by SKCa and IKCa channels. Reprod. Sci.14, 43–50 (2007).
   PubMed Web of Science ®Google Scholar
• Felipe A, Vicente R, Villalonga N et al. Potassium channels: new targets in cancer therapy. Cancer Detect. Prev.30, 375–385 (2006).
   PubMedGoogle Scholar
• Fioretti B, Castigli E, Micheli MR et al. Expression and modulation of the intermediate- conductance Ca2+-activated K+ channel in glioblastoma GL-15 cells. Cell Physiol. Biochem.18, 47–56 (2006).
   Google Scholar
• Jager H, Dreker T, Buck A et al. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol. Pharmacol.65, 630–638 (2004).
   PubMedGoogle Scholar
• Ouadid-Ahidouch H, Roudbaraki M, Delcourt P et al. Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression. Am. J. Physiol. Cell. Physiol.287, C125–C134 (2004).
   Google Scholar
• Parihar AS, Coghlan MJ, Gopalakrishnan M et al. Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur. J. Pharmacol.471, 157–164 (2003).
   PubMed Web of Science ®Google Scholar
• Tajima N, Schönherr K, Niedling S et al. Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1α and the von Hippel–Lindau protein. J. Physiol.571(Pt 2), 349–359 (2006).
   Google Scholar
• Schwab A, Reinhardt J, Schneider SW et al. K+ channel-dependent migration of fibroblasts and human melanoma cells. Cell. Physiol. Biochem.9, 126–132 (1999).
   PubMed Web of Science ®Google Scholar
• Chou CC. Blocking ion channel KCNN4 alleviates inflammation symptoms by arresting the synthesis of key pro-inflammatory factors. Presented at: International Business Communications Conference on Assays and Cellular Targets. Bellevue, WA, USA 17–19 October (2005).
   Google Scholar
• Khalid MH, Shibata S, Hiura T. Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro. J. Neurosurg.90, 918–927 (1999).
   Google Scholar
• Reich EP, Cui L, Yang L et al. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol.35, 1027–1036 (2005).
   PubMedGoogle Scholar
• Köhler R, Degenhardt C, Kühn M et al. Expression and function of endothelial Ca2+-activated K+ channels in human mesenteric artery. A single-cell reverse transcriptase-polymerase chain reaction in situ. Circ. Res.87, 496–503 (2000).
   PubMed Web of Science ®Google Scholar
• Takahashi H, Abe M, Sugawara T et al. Clotrimazole, an imidazole antimycotic, is a potent inhibitor of angiogenesis. Jpn. J. Cancer Res.89, 445–451 (1998).
   PubMedGoogle Scholar
• Grgic I, Eichler I, Heinau P et al. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler. Thromb. Vasc. Biol.25, 704–770 (2005).
   PubMedGoogle Scholar
• Shepherd MC, Duffy SM, Harris T et al. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation. Am. J. Respir. Cell Mol. Biol37, 525–531 (2007).
   PubMed Web of Science ®Google Scholar
• Mross K. Anti-angiogenesis therapy: concepts and importance of dosing schedules in clinical trials. Drug Resist. Updat.3, 223–235 (2000).
   Google Scholar
• Ghanshani S, Wulff H, Miller MJ. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem.275, 37137–37149 (2000).
   PubMed Web of Science ®Google Scholar
• Wulff H, Knaus HG, Pennington M et al. K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J. Immunol.173, 776–786 (2004).
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Musset B, Renigunta V et al. Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc. Natl Acad. Sci. USA101, 9479–9484 (2004).
   PubMed Web of Science ®Google Scholar
• Wulff H, Calabresi PA, Allie R et al. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J. Clin. Invest.111, 1703–1713 (2003).
   PubMed Web of Science ®Google Scholar
• Chandy KG, Wulff H, Beeton C et al. K+ channels as targets for specific immunomodulation. Trends Pharmacol. Sci.25, 280–289 (2004).
   PubMed Web of Science ®Google Scholar
• Heber-Katz E. The ups and downs of EAE. Int. Rev. Immunol.9, 277–285 (1993).
   Google Scholar
• Khachigian LM. Collagen antibody-induced arthritis. Nat. Protoc.1, 2512–2516 (2006).
   PubMed Web of Science ®Google Scholar
• Mahaut-Smith MP, Schlichter LC. Ca2+-activated K+ channels in human B lymphocytes and rat thymocytes. J. Physiol. (Lond.)415, 69–83 (1989).
   Google Scholar
• Moritoki Y, Lian ZX, Wulff H. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology45, 314–322 (2007).
   PubMedGoogle Scholar
• Engel P, Tedder TF. New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Leuk. Lymphoma13(Suppl. 1), 61–64 (1994).
   PubMed Web of Science ®Google Scholar
• Jonasson L, Holm J, Skalli O et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis6, 131–138 (1986).
   PubMedGoogle Scholar
• Toyama K, Saito T, Fujiwara Y et al. Intermediate conductance calcium-activated potassium channel, KCa3.1, plays an important role in macrophage (MØ) migration in atherosclerosis. FASEB J.21, 743.18 (2007) (Abstract).
   Google Scholar
• Tharp DL, Wamhoff BR, Turk JR et al. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am. J. Physiol. Heart Circ. Physiol.291, H2493–H2503 (2006).
   Google Scholar
• Köhler R, Wulff H, Eichler I et al. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation108, 1119–1125 (2003).
   PubMed Web of Science ®Google Scholar
• Mauler F, Hinz V, Horvath E et al. Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma. Eur. J. Neurosci.20, 1761–1768 (2004).
   Google Scholar
• Joiner WJ, Wang LY, Tang MD et al. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc. Natl Acad. Sci. USA94, 11013–11018 (1997).
   PubMed Web of Science ®Google Scholar
• Cruse G, Duffy SM, Brightling CE et al. Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax61, 880–885 (2006).
   PubMedGoogle Scholar
• Olsson N, Ulfgren AK, Nilsson G. Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann. Rheum. Dis.60, 187–193 (2001).
   Google Scholar
• Soucek L, Lawlor ER, Soto D et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat. Med.13, 1211–1218 (2007).
   PubMed Web of Science ®Google Scholar
• Whiteaker KL, Gopalakrishnan SM, Groebe D et al. Validation of FLIPR membrane potential dye for high throughput screening of potassium channel modulators. J. Biomol. Screen.6, 305–312 (2001).
   PubMed Web of Science ®Google Scholar
• Baxter DF, Kirk M, Garcia AF et al. A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels. J. Biomol. Screen.7, 79–85 (2002).
   PubMed Web of Science ®Google Scholar
• John VH, Dale TJ, Hollands EC et al. Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels. J. Biomol. Screen.12, 50–60 (2007).
   PubMed Web of Science ®Google Scholar
• Zhou BY, Ma W, Huang XY. Specific antibodies to the external vestibule of voltage-gated potassium channels block current. J. Gen. Physiol.111, 555–563 (1998).
   PubMed Web of Science ®Google Scholar
• Rauer H, Pennington M, Cahalan M et al. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J. Biol. Chem.274, 21885–21892 (1999).
   PubMed Web of Science ®Google Scholar
• Xu SZ, Zeng F, Lei M et al. Generation of functional ion-channel tools by E3 targeting. Nat. Biotechnol.23, 1289–1293 (2005).
   PubMed Web of Science ®Google Scholar